By Professor Glenda Halliday

Journal articles

Grunblatt E; Monoranu C; Apfelbacher M; Keller D; Michel T; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Mclean C; Halliday GM; Harper C; Deckert J; Roggendorf W; Riederer P, 2009, 'Tryptophan is a marker of human postmortem brain tissue quality', Journal of Neurochemistry, 110, pp. 1400 - 1408

Mevawalla N; Fung VS; Morris JC; Halliday GM, 2009, 'Unilateral rest tremor in vascular Parkinsonism associated with a contralateral lesion of the locus coeruleus', Movement Disorders, 24, pp. 1242 - 1244

Shepherd CE; Mccann H; Halliday GM, 2009, 'Variations in the neuropathology of familial Alzheimer's disease', ACTA Neuropathologica, 118, pp. 37 - 52

Piguet O; Double KL; Kril J; Harasty JA; Macdonald V; Mcritchie DA; Halliday GM, 2009, 'White matter loss in healthy ageing: A postmortem analysis', Neurobiology of Aging, 30, pp. 1288 - 1295

Hersey P; Halliday GM; Farrelly ML; DeSilva C; Lett M; Menzies SW, 2008, 'Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma', CANCER IMMUNOLOGY IMMUNOTHERAPY, 57, pp. 1039 - 1051, http://dx.doi.org/10.1007/s00262-007-0435-8

Halliday GM; Lyons JG, 2008, 'Inflammatory doses of UV may not be necessary for skin carcinogenesis', Photochemistry and Photobiology, 84, pp. 272 - 283, http://dx.doi.org/10.1111/j.1751-1097.2007.00247.x

Huang Y; Halliday GM; Mastaglia FL; Rowe DB; Sue CM, 2008, '410: Autosomal dominant late-onset Parkinson’s disease due to a novel A1442P mutation in the LRRK2 gene', Journal of Clinical Neuroscience, 15, pp. 344 - 345, http://dx.doi.org/10.1016/j.jocn.2007.07.023

Loy CT; Brooks BS; Taddei K; Patton A; McLean C; Halliday GM; Martins R; Kwok JB; Schofield PR, 2008, '417: A consanguineous family with Frontotemporal Dementia/Motor Neuron Disease', Journal of Clinical Neuroscience, 15, pp. 347 - 347, http://dx.doi.org/10.1016/j.jocn.2007.07.030

Halliday GM, 2008, 'Clarifying the pathological progression of Parkinson`s disease', ACTA Neuropathologica, 115, pp. 377 - 378, http://dx.doi.org/10.1007/s00401-008-0353-7

Murphy KE; Karaconji T; Hardman CD; Halliday GM, 2008, 'Excessive dopamine neuron loss in progressive supranuclear palsy', Movement Disorders, 23, pp. 607 - 610, http://dx.doi.org/10.1002/mds.21907

Sutherland GR; Mellick GD; Newman J; Double KL; Stevens J; Lee L; Rowe DB; Silburn PA; Halliday GM, 2008, 'Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson`s disease', American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, 147B, pp. 495 - 499, http://dx.doi.org/10.1002/ajmg.b.30633

Halliday GM; Mccann H, 2008, 'Human-based studies on alpha-synuclein deposition and relationship to Parkinson`s disease symptoms', Experimental Neurology, 209, pp. 12 - 21, http://dx.doi.org/10.1016/j.expneurol.2007.07.006

Huang Y; Song YC; Murphy KE; Holton J; Lashley T; Revesz T; Gai WP; Halliday GM, 2008, 'LRRK2 and parkin immuoreactivity in multiple system atrophy inclusions', ACTA Neuropathologica, 116, pp. 639 - 646

Young VG; Halliday GM; Kril J, 2008, 'Neuropathologic correlates of white matter hyperintensities', Neurology, 71, pp. 804 - 811

Elliott DA; Kim WS; Halliday GM; Garner B, 2008, 'P3‐294: Post‐translational modifications of apolipoprotein‐e in the human brain', Alzheimer's & Dementia, 4, http://dx.doi.org/10.1016/j.jalz.2008.05.1862

Luty A; Kwok JB; Thompson E; Blumbergs PC; Brooks WS; Loy CT; Dobson-Stone C; Panegyres P; Hecker J; Nicholson GA; Halliday GM; Schofield PR, 2008, 'Pedigree with frontotemporal lobar degeneration - motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9', BMC NEUROLOGY, 8

Double KL; Dedov V; Fedorow HS; Kettle E; Halliday GM; Garner B; Brunk U, 2008, 'The comparative biology of neuromelanin and lipofuscin in the human brain', CMLS - Cellular and Molecular Life Sciences, 65, pp. 1669 - 1682, http://dx.doi.org/10.1007/s00018-008-7581-9

Halliday GM; Hely MA; Reid WG; Morris JG, 2008, 'The progression of pathology in longitudinally followed patients with Parkinson`s disease', ACTA Neuropathologica, 115, pp. 409 - 415, http://dx.doi.org/10.1007/s00401-008-0344-8

Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG, 2008, 'The Sydney multicenter study of Parksinon`s disease: The inevitability of dementia at 20 years', Movement Disorders, 23, pp. 837 - 844

Karlstrom H; Brooks WS; Kwok JB; Broe T; Kril J; Mccann H; Halliday GM; Schofield PR, 2008, 'Variable phenotype of Alzheimer's disease with spastic paraparesis', Journal of Neurochemistry, 104, pp. 573 - 583, http://dx.doi.org/10.1111/j.1471-4159.2007.05038.x

Christine Song YJ; Huang Y; Lundvig D; Gai WP; Blumbergs P; Hojrup P; Otzen D; Halliday G; Jensen P, 2007, '1.210 P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy', Parkinsonism & Related Disorders, 13, pp. S63 - S63, http://dx.doi.org/10.1016/s1353-8020(08)70483-8

Stevens J; Huang Y; Vandenbona H; Halliday GM; Mellick G; Mastaglia F; Kwok J; Sue CM, 2007, '307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease', Journal of Clinical Neuroscience, 14, pp. 1009 - 1010, http://dx.doi.org/10.1016/j.jocn.2007.02.013

Piguet O; Bennett HP; Waite LM; Kril JJ; Creasey H; Broe GA; Halliday GM, 2007, '619: Preserved cognition and functional independence after a large right PCA infarct: longitudinal clinical and neuropathological findings', Journal of Clinical Neuroscience, 14, pp. 1023 - 1024, http://dx.doi.org/10.1016/j.jocn.2007.02.050

Schofield EC; McCredie RL; Halliday GM; Cordato NJ, 2007, '621: Changes in regional cerebral blood flow relate to cognitive and behavioural symptoms in progressive supranuclear palsy', Journal of Clinical Neuroscience, 14, pp. 1024 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.052

Brooks DJ; Harding AJ; Halliday GM, 2007, '622: Visual hallucinations and fluctuating consciousness relate to pathology of the limbic thalamus in Lewy body dementias', Journal of Clinical Neuroscience, 14, pp. 1025 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.053

Sutherland GT; Sue C; Mellick GD; Lee L; Rowe DB; Silburn PA; Halliday GM, 2007, '643: Promotor polymorphisms lowering parkin expression reduce the age of onset of Parkinson’s disease', Journal of Clinical Neuroscience, 14, pp. 1033 - 1033, http://dx.doi.org/10.1016/j.jocn.2007.02.074

Sutherland GT; Mellick GD; Sue C; Chan DK; Rowe DB; Silburn PA; Halliday GM, 2007, 'A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson`s disease', Neuroscience Letters, 414, pp. 170 - 173

Kipps C; Davies R; Mitchell J; Kril J; Halliday GM; Hodges JR, 2007, 'Clinical significance of lobar atrophy in frontotemporal dementia: Application of an MRI visual rating scale', Dementia and Geriatric Cognitive Disorders, 23, pp. 334 - 342

Dedov V; Griffiths F; Garner B; Halliday GM; Double KL, 2007, 'Lipid content determines aggregation of neuromelanin granules in vivo', Journal of Neural Transmission - Supplement, 72, pp. 35 - 38

Cairns NJ; Bigio E; Mackenzie IR; Neumann M; Lee VM; Hatanpaa K; White CL; Schneider JA; Grinberg LT; Halliday GM; Duyckaerts C; Lowe JL; Holm I; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson D; Ince PG; Trojanowski JQ; Mann DM, 2007, 'Neuropathological diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration', ACTA Neuropathologica, 114, pp. 5 - 22

Song YC; Lundvig DM; Huang Y; Gai WP; Blumbergs PC; Hojrup P; Otzen D; Halliday GM; Jensen PH, 2007, 'p25alpha relocalizes in oligodedroglia from myelin to cytoplasmic inclusions in multiple system atrophy', American Journal of Pathology, 171, pp. 1291 - 1303

Taylor JM; Song YC; Huang Y; Farrer M; Delatycki MB; Halliday GM; Lockhart PJ, 2007, 'Parkin co-regulated gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of parkinsonian diseases', Neurobiology of Disease, 27, pp. 238 - 247

Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok JB; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio J; Sue C, 2007, 'Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson`s disease', Movement Disorders, 27, pp. 982 - 989

Shepherd CE; Grace E; Mann DM; Halliday GM, 2007, 'Relationship between neuronal loss and 'inflammatory plaques' in early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, 33, pp. 328 - 333

Behnke S; Double KL; Duma SR; Broe T; Guenther V; Becker GJ; Halliday GM, 2007, 'Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing', Neuroimage, 34, pp. 1054 - 1059

Sutherland GR; Nowak G; Halliday GM; Kril J, 2007, 'Tau isoform expression in frontotemporal dementia without tau deposition', Journal of Clinical Neuroscience, 14, pp. 1182 - 1185

Litvan I; Halliday GM; Hallett M; Goetz CG; Rocca W; Duyckaerts C; Ben-Shlomo Y; Dickson D; Lang A; Chesselet M; Langston WJ; Di Monte DA; Gasser T; Hagg T; Hardy J; Jenner P; Melamed E; Myers RH; Parker Jr D; Price D, 2007, 'The etiopathogenesis of Parkinson Disease and suggestions for future research. Part 1', Journal of Neuropathology and Experimental Neurology, 66, pp. 251 - 257

Litvan I; Chesselet M; Gasser T; Di Monte DA; Parker Jr D; Hagg T; Hardy J; Jenner P; Myers RH; Price D; Hallett M; Langston WJ; Lang A; Halliday GM; Rocca W; Duyckaerts C; Dickson D; Ben-Shlomo Y; Goetz CG; Melamed E, 2007, 'The etiopathogenesis of parkinson disease and suggestions for future research. Part II', Journal of Neuropathology and Experimental Neurology, 66, pp. 329 - 336

Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Neurobiology of Aging, 27, pp. 506 - 512, http://dx.doi.org/10.1016/j.neurobiolaging.2005.02.015

Ritchie CW; Chiu E; Harrigan S; Macfarlane S; Mastwyk M; Halliday G; Hustig H; Hall K; Hassett A; O'Connor DW; Opie J; Nagalingam V; Snowdon J; Ames D, 2006, 'A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration', INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 21, pp. 171 - 179, http://dx.doi.org/10.1002/gps.1446

Piguet O; Bennett HP; Waite LM; Kril JJ; Creasey H; Broe GA; Halliday GM, 2006, 'Absence of cognitive deficits and preserved functional independence after a large right PCA infarct: Longitudinal clinical and neuropathological findings', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 58, pp. 229 - 229, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000242541400830&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ooi T; Barnetson RS; Zhuang L; McKane S; Lee JH; Slade HB; Halliday GM, 2006, 'Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: A randomized controlled trial', British Journal of Dermatology, 154, pp. 72 - 78, http://dx.doi.org/10.1111/j.1365-2133.2005.06932.x

de Silva R; Lashley T; Strand C; Shiarli A; Shi J; Tian J; Bailey K; Davies P; Bigio E; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday GM; MacKenzie J; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown S; Holton J; Lees A; Revesz T; Mann DM, 2006, 'An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies', ACTA Neuropathologica, 111, pp. 329 - 340

Huang Y; Hayes M; Harding AJ; Brooks WS; Fung VS; Rowe DB; Joffe R; Crimmins D; Hely MA; Halliday GM, 2006, 'Anticipation of onset age in familial Parkinson`s disease without SCA gene mutations', Parkinsonism and Related Disorders, 12, pp. 309 - 313

Rahimi F; Shepherd CE; Halliday GM; Geczy C; Raftery MJ, 2006, 'Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue', Analytical Chemistry, 78, pp. 7216 - 7221, http://dx.doi.org/10.1021/ac060294s

David DJ; Ittner L; Gehrig P; Nergenau D; Shepherd CE; Halliday GM; Gotz J, 2006, 'Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes', Proteomics, 6, pp. 6566 - 6577

Bennett HP; Piguet O; Grayson DA; Creasey H; Waite LM; Lye TC; Broe T; Halliday GM, 2006, 'Cognitive, Extrapyramidal, and Magnetic Resonance Imaging Predictors of Functional Impairment in Nondemented Older Community Dwellers: The Sydney Older Person Study', Journal of American Geriatrics Society, 54, pp. 3 - 10

Shiarli A; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio E; Ghetti B; Murrell J; Delisle M; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday GM; MacKenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown S; Mann DM, 2006, 'Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, 32, pp. 374 - 387

Cordato N; Halliday GM; Caine D; Morris JG, 2006, 'Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson`s disease', Movement Disorders, 21, pp. 632 - 638

Halliday GM; Del Tredici K; Braak H, 2006, 'Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson`s disease', Journal of Neural Transmission - Supplement, pp. 99 - 103

Back to profile page